Panacea Biotec informs about updates

28 Oct 2023 Evaluate

Panacea Biotec has informed that about the launch of Paclitaxel Protein-Based Particles for Injectable Suspension (Albumin - Bound), a generic version of Abraxane in the Canadian market by its material wholly-owned subsidiary company viz. Panacea Biotec Pharma through its strategic partner Apotex Inc., Canada.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

362.00 -6.60 (-1.79%)
23-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×